SOURCE: ChromaDex Corporation

May 21, 2013 09:15 ET Insider Buy Breaking Alert: ChromaDex Director Buys 25,000 Shares in Open Market

REDONDO BEACH, CA--(Marketwired - May 21, 2013) -  ChromaDex Corporation (OTCQB: CDXC) Director Michael Brauser purchased 25,000 shares of common stock on the open market on May 13th, according to a Form 4 filing made with the SEC. These purchases took place at $0.662 per share, bringing the insider's total ownership stake to 4,519,926 shares owned directly by Mr. Brauser.

View the Form 4 filing from here:

Michael Brauser, 57, has served as Co-Chairman of the Board since October 2011 and served on the Compensation Committee from May 2010 to March 2011. Mr. Brauser has been the manager of, and investor with, Marlin Capital Partners LLC, a private investment company, since 2003. From 1999 to 2002, he served as President and Chief Executive Officer of Naviant Inc. (eDirect Inc.), an Internet marketing company. He was also the founder of Seisant Inc. ( Inc.). Mr. Brauser also served as Co-Chairman of the Board of Directors of InterCLICK Inc. -- now a part of Yahoo Inc., from August 2007 to December 2011. With his past experience as Co-Chairman of the Board of Directors at InterCLICK and as manager of an investment company, he brings extensive business and management expertise to the board.

About ChromaDex Corporation

ChromaDex® is an innovative natural products company that discovers, acquires, develops and commercializes proprietary-based ingredient technologies through its unique business model which utilizes its wholly-owned synergistic business units, including ingredient technologies, natural product fine chemicals (known as "phytochemicals"), chemistry and analytical testing services, and product regulatory and safety consulting (as Spherix Consulting). The Company provides seamless science-based solutions to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries. Our ingredient technologies unit includes products backed with extensive scientific research and intellectual property. The ingredient portfolio includes pTeroPure®pterostilbene; ProC3G™, a natural black rice containing cyanidine-3-glucoside; PURENERGY™, a caffeine-pTeroPure co-crystal; nutraGac™, a gac fruit powder; curcumin, and nicotinamide riboside, a novel next-generation B-vitamin currently under development.

About is a leading provider of SEC filings news and analysis, with more than 600,000 registered members. By providing real-time SEC filing alerts by e-mail or RSS, as well as access to an extensive database of over 7 million filings dating back to 1994, the financial portal has become a leading destination for sophisticated investors looking to track regulatory filings.

Please see the full disclaimer pertaining to this release here: